Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Most S&P 500 Firms Beat EPS Expectations but Fell Short on Revenue This Week - Earnings Scorecard
Analyst Expectations For Vertex Pharmaceuticals's Future
During the last three months, 10 analysts shared their evaluations of Vertex Pharmaceuticals (NASDAQ:VRTX), revealing diverse outlooks from bullish to bearish.The following table summarizes their rece
Vertex Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 12.87% BMO Capital $480 → $500 Maintains Outperform 05/07/2024 -4.29% RBC Capital $417 → $424 M
Apellis Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 12.88% Piper Sandler → $46 Initiates Coverage On → Neutral 05/28/2024 125.77% HC Wainwright & C
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares. This move comes as Robinhood launches
Nektar, Verastem Among Healthcare Additions in Russell Microcap; Assertio, Sangamo Removed